October 25, 2014 12:34 AM ET

Pharmaceuticals

Company Overview of Warner-Lambert Company LLC

Executive Profile

Lodewijk J. R. de Vink

Former Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee, Flamel Technologies SA
AgeTotal Calculated CompensationThis person is connected to 8 Board Members in 8 different organizations across 13 different industries.

See Board Relationships
69--

Background

Mr. Lodewijk J. R. de Vink served as the Special Advisor and Consultant of Blackstone Healthcare Advisors at The Blackstone Group L.P. Mr. de Vink has more than 40 years experience in the pharmaceutical and healthcare industries. He was the Chairman and Chief Executive Officer of Warner Lambert Company LLC. Mr. de Vink joined Warner-Lambert in 1988 as Vice President and President, International Operations. Previously, from 1978 to 1988, he was employed by Schering-Plough ...

Corporate Headquarters

201 Tabor Road
Morris Plains, New Jersey 07950

United States

Phone: 973-385-2000
Fax: 201-540-3761

Board Members Memberships

Director
Director
Former Director
Member of the Board of Managers
Director
1991-N/A
President, Chief Operating Officer and Director
1995-N/A
Former Director
2002-Present
Director, Chairman of Compensation Committee, Member of Audit Committee, Member of Nominating/Corporate Governance Committee and Member of Independent Director Committee
2004-2013
Former Director and Member of Audit Committee
2006-N/A
Former Director, Chairman of Compensation Committee and Member of Nominating & Corporate Governance Committee
2007-Present
Director

Education

MBA 1969
American University
BBA 1968
Washburn University, Topeka
Unknown/Other Education
Nyenrode Business Universiteit

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
James E. Brown D.V.M.Co-Founder, Chief Executive Officer, President and Director
DURECT Corporation
$450.7K
Ronald W. Barrett Ph.D.Co-Founder, Chief Executive Officer and Director
Xenoport, Inc.
$500.0K
Judith Greciet Ph.D., PharmacyChief Executive Officer, Director and Member of Corporate Development Committee
Onxeo SA
$276.9K
Mark A. Sirgo Pharm.D.Chief Executive Officer, President, Chief Scientific Officer, Executive Director and Member of Executive Subcommittee
BioDelivery Sciences International, Inc.
$739.3K
William J. Polvino M.D.Chief Executive Officer and President
Veloxis Pharmaceuticals A/S
--
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Warner-Lambert Company LLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.